Co-Diagnostics to Participate in Three Global Tuberculosis Events in November as CoSara Advances Toward Anticipated India Launch

Article summary

Events in Bali and Rio de Janeiro Bring Together Global Health Leaders to Address Tuberculosis Diagnosis, Treatment and Prevention SALT LAKE CITY, Nov. 5, 2026 — Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique,...